Caris Life Sciences, Inc. (CAI) shareholders
Close on Nov 17, 2026Market cap $5.63BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| David D. Halbert Joint filing with Caris Halbert, L.P. (36.00%) | 124,906,296 | 44.10% | 13G (passive) | Jun 30, 2025 |
| Abigail P. Johnson Joint filing with FMR LLC (13.40%) | 37,795,317 | 13.40% | 13G (passive) amendment | Sep 30, 2026 |
| J. H. Whitney Equity Partners VI, LLC Joint filing with J H Whitney VI LP (7.30%), Vigano Paul R (7.30%) and 1 more | 20,256,615 | 7.30% | 13G (passive) | Jun 30, 2025 |
| FMR LLC Joint filing with Abigail P. Johnson (5.00%) | 14,143,768 | 5.00% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CAI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 30,923,878 | 10.94% | $551.06M | +138,293 | 0.02% |
| J. H. Whitney Equity Partners VI, LLC | 11,256,615 | 3.98% | $200.59M | −7,000,000 | 100.00% |
| Coatue Management LLC | 9,819,992 | 3.47% | $174.99M | – | 0.36% |
| Braidwell LP | 8,256,032 | 2.92% | $147.12M | +246,585 | 5.44% |
| Sixth Street Partners Management Company, L.P. | 7,327,041 | 2.59% | $130.57M | −7,058,358 | 22.54% |
| PointState Capital LP | 6,828,835 | 2.42% | $121.69M | −531,611 | 1.56% |
| JPMorgan Chase & Co | 6,558,514 | 2.32% | $120.24M | +3,098,299 | 0.01% |
| BlackRock, Inc. | 5,536,798 | 1.96% | $98.67M | +679,686 | 0.00% |
| T. Rowe Price Investment Management, Inc. | 5,079,141 | 1.80% | $90.51M | −509,116 | 0.06% |
| Vanguard Portfolio Management LLC | 4,844,431 | 1.71% | $86.33M | +1,085,969 | 0.00% |
| Vanguard Capital Management LLC | 4,280,238 | 1.51% | $76.27M | +951,217 | 0.00% |
| Los Angeles Capital Management LLC | 3,958,531 | 1.40% | $70.54M | +1,668,929 | 0.26% |
| Neuberger Berman Group LLC | 3,590,963 | 1.27% | $63.99M | +377 | 0.04% |
| Orbimed Advisors LLC | 2,806,811 | 0.99% | $50.02M | – | 0.93% |
| Bnp Paribas Arbitrage, Snc | 2,370,268 | 0.84% | $42.24M | +755,982 | 0.01% |
| Millennium Management LLC | 2,202,647 | 0.78% | $39.25M | +674,891 | 0.01% |
| Mak Capital One LLC | 1,937,229 | 0.69% | $34.52M | New | 4.84% |
| Morgan Stanley | 1,935,531 | 0.68% | $34.49M | +856,114 | 0.00% |
| Duquesne Family Office LLC | 1,894,450 | 0.67% | $33.76M | – | 0.65% |
| Clearbridge Investments, LLC | 1,595,877 | 0.56% | $28.44M | +44,103 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 246 | 154M | 54.5% | 69 / 105 | 47 / 24 | 23M | 26M |
| Q1 2026 | 202 | 157M | 55.5% | 57 / 87 | 39 / 36 | 42M | 35M |
| Q4 2025 | 186 | 149M | 52.8% | 77 / 63 | 30 / 27 | 55M | 19M |
| Q3 2025 | 138 | 114M | 40.4% | 53 / 46 | 18 / 31 | 12M | 7M |
| Q2 2025 | 116 | 109M | 38.7% | 116 / 0 | 0 / 0 | 109M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
224 funds held CAI in Q2 2026, 21% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CAI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 4,047,820 | 1.43% | $72.13M | 0.00% | Jun 30, 2026 |
| Select Health Care Portfolio | 3,750,000 | 1.33% | $62.70M | 1.08% | May 31, 2026 |
| JPMorgan Mid Cap Growth Fund | 3,320,983 | 1.18% | $59.18M | 0.45% | Jun 30, 2026 |
| Fidelity Contrafund | 3,075,220 | 1.09% | $54.80M | 0.03% | Jun 30, 2026 |
| Select Medical Technology and Devices Portfolio | 3,000,000 | 1.06% | $50.16M | 1.68% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 2,921,307 | 1.03% | $52.06M | 0.03% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 2,898,600 | 1.03% | $48.46M | 0.02% | May 31, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 2,702,379 | 0.96% | $48.16M | 0.21% | Jun 30, 2026 |
| VIP Mid Cap Portfolio | 2,576,270 | 0.91% | $45.91M | 0.48% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,686,026 | 0.60% | $30.04M | 0.06% | Jun 30, 2026 |
| Fidelity U.S. Equity Central Fund | 1,369,711 | 0.48% | $24.41M | 0.10% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 1,180,173 | 0.42% | $21.03M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 961,340 | 0.34% | $15.06M | 0.17% | Jul 31, 2026 |
| Fidelity Advisor Health Care Fund | 933,749 | 0.33% | $14.63M | 0.47% | Jul 31, 2026 |
| JNL/JPMorgan MidCap Growth Fund | 907,294 | 0.32% | $16.17M | 0.45% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brian J. Brille | See Remarks, Director | 1,130,303 | 0.40% | Sep 17, 2026 |
| David D. Halbert | See Remarks, Director, 10% owner | 123,599,535 | 43.74% | May 18, 2026 |
| John Russel Denton | See Remarks | 184,039 | 0.07% | Sep 23, 2026 |
| David Baxley Spetzler | President | 1,302,083 | 0.46% | Sep 4, 2026 |
| Luke Thomas Power | See Remarks | 153,771 | 0.05% | May 18, 2026 |
| Laura I. Johansen | Director | 343,897 | 0.12% | Aug 14, 2026 |
| T. Danny Phillips | Director | 133,060 | 0.05% | Aug 14, 2026 |
| David Paul Fredrickson | Director | 31,813 | 0.01% | Aug 14, 2026 |
| Peter M. Castleman | Director | 10,683,714 | 3.78% | Aug 14, 2026 |
| Jeff L. Vacirca | Director | 62,863 | 0.02% | Aug 14, 2026 |
| Jon Halbert | Director | 1,490,406 | 0.53% | Aug 14, 2026 |
| Lloyd Minor | Director | 31,813 | 0.01% | Aug 14, 2026 |
| Joseph E. Gilliam | Director | 29,321 | 0.01% | Aug 14, 2026 |
| Jonathan Kenneth Charles Knowles | Director | 308,979 | 0.11% | Jun 2, 2026 |
| George Poste | Director | 529,431 | 0.19% | Jun 2, 2026 |
| Caris Halbert, L.P. | Director, 10% owner | 123,462,091 | 43.69% | Jun 23, 2025 |
| Paul R. Vigano | 10% owner | – | – | Jun 23, 2025 |
| J. H. Whitney Equity Partners VI, LLC | 10% owner | – | – | Jun 23, 2025 |
| H. Whitney VI L. P. J | 10% owner | 7,739,781 | 2.74% | Jun 23, 2025 |
| Alan Waxman | – | – | – | Jun 23, 2025 |
| I. Ltd. ADAPT | 10% owner | 16,943,232 | 6.00% | Jun 23, 2025 |
| Carisome I, L.P. | 10% owner | – | – | Jun 23, 2025 |
| Sub-Fund HoldCo LLC TSSP | – | 23,644,907 | 8.37% | Jun 23, 2025 |
| Robert M. Williams Jr | 10% owner | 20,256,615 | 7.17% | Jun 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John Russel Denton See Remarks | Sep 22, 2026 | Sale | −7,500 | $31.82 | $238.65K | 174,855 |
| Brian J. Brille See Remarks, Director | Sep 17, 2026 | Option exercise | +400,000 | $2.44 | $976.00K | 630,303 |
| Brian J. Brille See Remarks, Director | Sep 17, 2026 | Sale | −400,000 | $30.33 | $12.13M | 230,303 |
| David Baxley Spetzler President | Sep 4, 2026 | Option exercise | +250,000 | $2.44 | $610.00K | 1,302,083 |
| David Baxley Spetzler President | Sep 4, 2026 | Sale | −119,212 | $24.76 | $2.95M | 1,182,871 |
| David Baxley Spetzler President | Sep 3, 2026 | Sale | −84,900 | $25.32 | $2.15M | 1,052,083 |
| David Baxley Spetzler President | Sep 3, 2026 | Sale | −393,100 | $24.76 | $9.73M | 1,136,983 |
| David Baxley Spetzler President | Sep 3, 2026 | Option exercise | +1,000,000 | $2.44 | $2.44M | 1,530,083 |
| Lloyd Minor Director | Aug 14, 2026 | Award | +13,192 | – | – | 31,813 |
| Jon Halbert Director | Aug 14, 2026 | Award | +13,192 | – | – | 131,813 |
| Jeff L. Vacirca Director | Aug 14, 2026 | Award | +13,192 | – | – | 62,863 |
| Laura I. Johansen Director | Aug 14, 2026 | Award | +13,192 | – | – | 343,897 |
| Peter M. Castleman Director | Aug 14, 2026 | Award | +13,192 | – | – | 29,321 |
| David Paul Fredrickson Director | Aug 14, 2026 | Award | +13,192 | – | – | 31,813 |
| T. Danny Phillips Director | Aug 14, 2026 | Award | +13,192 | – | – | 133,060 |
| Joseph E. Gilliam Director | Aug 14, 2026 | Award | +13,192 | – | – | 29,321 |
| Jonathan Kenneth Charles Knowles Director | May 29, 2026 | Award | +1,600 | $15.62 | $24.99K | 308,979 |
| George Poste Director | May 29, 2026 | Award | +1,600 | $15.62 | $24.99K | 17,729 |
| Jon Halbert Director | May 15, 2026 | Buy | +68,000 | $14.56 | $990.08K | 704,598 |
| Luke Thomas Power See Remarks | May 15, 2026 | Tax withholding | −9,771 | $15.25 | $149.01K | 153,771 |
| David D. Halbert See Remarks, Director, 10% owner | May 15, 2026 | Tax withholding | −40,712 | $15.25 | $620.86K | 2,574,533 |
| Brian J. Brille See Remarks, Director | May 15, 2026 | Tax withholding | −13,987 | $15.25 | $213.30K | 230,303 |
| David Baxley Spetzler President | May 15, 2026 | Tax withholding | −13,856 | $15.25 | $211.30K | 530,083 |
| John Russel Denton See Remarks | May 15, 2026 | Tax withholding | −6,047 | $15.25 | $92.22K | 181,515 |
| Jeff L. Vacirca Director | May 11, 2026 | Buy | +31,050 | $16.15 | $501.46K | 49,671 |
| Brian J. Brille See Remarks, Director | Mar 6, 2026 | Award | +83,162 | – | – | 244,290 |
| Luke Thomas Power See Remarks | Mar 6, 2026 | Award | +63,971 | – | – | 163,542 |
| David Baxley Spetzler President | Mar 6, 2026 | Award | +83,162 | – | – | 543,939 |
| John Russel Denton See Remarks | Mar 6, 2026 | Award | +63,971 | – | – | 187,562 |
| David D. Halbert See Remarks, Director, 10% owner | Mar 6, 2026 | Award | +320,112 | – | – | 2,615,245 |
| Lloyd Minor Director | Feb 26, 2026 | Award | +2,492 | $20.06 | $49.99K | 18,621 |
| Jon Halbert Director | Feb 26, 2026 | Award | +2,492 | $20.06 | $49.99K | 118,621 |
| David Paul Fredrickson Director | Feb 26, 2026 | Award | +2,492 | $20.06 | $49.99K | 18,621 |
| Jeff L. Vacirca Director | Feb 26, 2026 | Award | +2,492 | $20.06 | $49.99K | 18,621 |
| Peter M. Castleman Director | Feb 26, 2026 | Award | +5,509 | $20.06 | $110.51K | 24,138 |
| T. Danny Phillips Director | Feb 26, 2026 | Award | +3,739 | $20.06 | $75.00K | 119,868 |
| Peter M. Castleman Director | Jan 9, 2026 | Option exercise | +2,500 | $18.60 | $46.50K | 18,629 |
| Luke Thomas Power See Remarks | Dec 11, 2025 | Option exercise | +37,500 | $2.44 | $91.50K | 161,821 |
| Luke Thomas Power See Remarks | Dec 11, 2025 | Sale(10b5-1 plan) | −60,850 | $26.56 | $1.62M | 100,971 |
| Luke Thomas Power See Remarks | Dec 11, 2025 | Sale(10b5-1 plan) | −1,400 | $27.16 | $38.02K | 99,571 |
| Luke Thomas Power See Remarks | Dec 11, 2025 | Option exercise | +24,750 | $2.44 | $60.39K | 124,321 |
| Brian J. Brille See Remarks, Director | Dec 11, 2025 | Gift | −650 | – | – | 161,128 |
| Brian J. Brille See Remarks, Director | Dec 10, 2025 | Gift | −650 | – | – | 161,778 |
| John Russel Denton See Remarks | Nov 7, 2025 | Buy | +4,184 | $24.09 | $100.79K | 9,184 |
| David Baxley Spetzler President | Nov 7, 2025 | Buy | +400 | $23.85 | $9.54K | 460,777 |
| T. Danny Phillips Director | Sep 11, 2025 | Option exercise | +100,000 | $2.44 | $244.00K | 116,129 |
| George Poste Director | Aug 11, 2025 | Option exercise | +125,000 | $2.44 | $305.00K | 359,754 |
| George Poste Director | Aug 11, 2025 | Tax withholding | −48,022 | $29.75 | $1.43M | 311,732 |
| George Poste Director | Aug 11, 2025 | Tax withholding | −91,495 | $29.75 | $2.72M | 220,237 |
| David D. Halbert See Remarks, Director, 10% owner | Aug 11, 2025 | Tax withholding | −141,956 | $29.75 | $4.22M | 2,295,133 |
| David Baxley Spetzler President | Aug 11, 2025 | Tax withholding | −63,509 | $29.75 | $1.89M | 460,377 |
| John Russel Denton See Remarks | Jun 20, 2025 | Buy | +7,500 | $21.00 | $157.50K | 123,591 |
| Caris Halbert, L.P. Director, 10% owner | Jun 20, 2025 | Conversion | +104,761,535 | – | – | 121,025,002 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Option exercise | +1,711,113 | – | – | 5,687,176 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Conversion | +10,103,175 | – | – | 10,103,175 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Option exercise | +2,255,048 | – | – | 3,976,063 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Conversion | +478,779 | – | – | 478,779 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Conversion | +3,493,789 | – | – | 3,493,789 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Conversion | +3,881,988 | – | – | 3,881,988 |
| Sub-Fund HoldCo LLC TSSP – | Jun 20, 2025 | Conversion | +1,721,015 | – | – | 1,721,015 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Caris Life Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 390,037 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John Russel Denton Officer | Sep 22, 2026 | 7,500 | $238.63K | Sep 22, 2026 | Private Acquisition from Issuer/Affiliate |
| Brian J. Brille Officer, Director | Sep 17, 2026 | 400,000 | $12.13M | Sep 17, 2026 | Exercise of Options Under a Registered Plan |
| David Baxley Spetzler Officer | Sep 4, 2026 | 119,212 | $2.95M | Sep 4, 2026 | Exercise of Options Under a Registered Plan |
| David Baxley Spetzler Officer | Sep 3, 2026 | 478,000 | $11.88M | Sep 3, 2026 | Exercise of Options Under a Registered Plan |
| George H Poste Revocable Trust Former Affiliate | Aug 24, 2026 | 100,000 | $2.61M | Aug 24, 2026 | Previously Exercised Options |
| George Poste Director | Aug 7, 2026 | 30,000 | $642.63K | Aug 7, 2026 | Stock Option Exercise |
| George Poste Director | Aug 3, 2026 | 20,000 | $325.00K | Aug 3, 2026 | Stock Option Exercise |
| Luke Thomas Power Officer | Dec 11, 2025 | 62,250 | $1.69M | Dec 11, 2025 | Exercise of Stock Options |
See a number that looks wrong?